Not exact matches
Lead researcher Dr Sarah Kingsbury, from the University of Leeds and NIHR Leeds Biomedical Research Centre at Chapel Allerton Hospital, said: «There is some scientific basis as to why
hydroxychloroquine could be an effective
drug agent.
Hydroxychloroquine is an antimalarial
drug that is also used to treat rheumatoid arthritis and lupus erythematosus.
«It is likely that physicians add either sulfasalazine or
hydroxychloroquine one at a time to see if each
drug works and is tolerated before adding the next
drug.
Distinct non-cancer
drugs already investigated in clinical cancer trials comprise metformin, aspirin,
hydroxychloroquine and thalidomide [3, 4].
Hydroxychloroquine is an antimalarial
drug which is relatively safe and well - tolerated agent for the treatment of rheumatoid arthritis.
For mild cases, ibuprofen and naproxen can reduce pain and swelling in joints and muscles, and antimalarial
drugs like Plaquenil (generic:
hydroxychloroquine) have proven useful in preventing flares and controlling the diseases progression.